Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-06-15
1999-08-31
Huang, Evelyn Mei
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 93, A61K 3144, C07D40104, C07D40114
Patent
active
059454300
ABSTRACT:
Novel aminooxyamide tricyclic compounds and pharmaceutical compositions are disclosed which are inhibitors of the enzyme, farnesyl protein transferase. Also disclosed is a method of inhibiting Ras function and therefore inhibiting the abnormal growth of cells. The method comprises administering the novel aminooxyamide tricyclic compound to a biological system. In particular, the method inhibits the abnormal growth of cells in a mammals such as a human.
REFERENCES:
patent: 5438062 (1995-08-01), Piwinski et al.
patent: 5665726 (1997-09-01), Piwinski et al.
patent: 5696121 (1997-12-01), Bishop
Khosravi-Far R et al. Cell Growth & Differentiation. 3, 461-9, Jul. 1992.
Doll Ronald J.
Lalwani Tarik
Huang Evelyn Mei
Majka Joseph T.
Schering Corporation
LandOfFree
Aminooxyamide tricyclic inhibitors of farnesyl-protein transfera does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminooxyamide tricyclic inhibitors of farnesyl-protein transfera, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminooxyamide tricyclic inhibitors of farnesyl-protein transfera will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2426591